HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearchCompany Lookup

Tracking Key Mental Health and Substance Use Policy Actions Under the Trump Administration

A new KFF tracker highlights key federal policy actions during President Trump's second term that concern issues related to mental health and substance use. The second Trump administration has emphasized law-and-order strategies and scaled back several mental health and substance use-related service

By KFF Health News · Jul 10, 2026 · via KFF Health News
Tracking Key Mental Health and Substance Use Policy Actions Under the Trump Administration

Image: KFF Health News

This is an aggregated industry headline. Read the full story at KFF Health News

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineKFF Health News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Bayer has addressed its need for a capital infusion under a deal to secure 3 billion euros ($3.4 billion) in e…
Jul 12, 2026
The WeekFierceBiotech ↗
KKR, the global investment giant, has launched Allyntra as a new, precision-engineered solutions platform for …
Jul 12, 2026
FDA broadens Padcev-Keytruda bladder cancer approval, tightening competition for AstraZeneca
The WeekBriefing
The FDA has expanded the use of the Padcev-Keytruda combination in bladder cancer, intensifying competition fo…
Jul 12, 2026